Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug - Reuters

Reuters | May 19, 2025, 8:40 p.m. | Original
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug Reuters
Five of China's major state banks cut deposit rates - Reuters Brazil's antitrust body to approve Petz, Cobasi merger, local media reports - Reuters